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ABSTRACT
The H19 lncRNA has been implicated in develop-
ment and growth control and is associated with
human genetic disorders and cancer. Acting as a
molecular sponge, H19 inhibits microRNA (miRNA)
let-7. Here we report that H19 is significantly de-
creased in muscle of human subjects with type-2 di-
abetes and insulin resistant rodents. This decrease
leads to increased bioavailability of let-7, causing
diminished expression of let-7 targets, which is re-
capitulated in vitro where H19 depletion results in
impaired insulin signaling and decreased glucose
uptake. Furthermore, acute hyperinsulinemia down-
regulates H19, a phenomenon that occurs through
PI3K/AKT-dependent phosphorylation of the miRNA
processing factor KSRP, which promotes biogen-
esis of let-7 and its mediated H19 destabilization.
Our results reveal a previously undescribed double-
negative feedback loop between sponge lncRNA and
target miRNA that contributes to glucose regulation
in muscle cells.
INTRODUCTION
The H19 long noncoding RNA (lncRNA) is transcribed
from a conserved imprinted gene cluster that also con-
tains the nearby Igf2 gene encoding insulin-like growth fac-
tor 2 (1). The two genes are reciprocally imprinted, with
H19 being maternally and Igf2 paternally expressed. Both
genes are highly expressed during fetal life and are strongly
down-regulated after birth, except for persistent expres-
sion of H19 in adult skeletal muscle and heart. H19 en-
codes a 2.6 kb capped, spliced and polyadenylated non-
coding RNA that is predominantly cytoplasmic, with a
minor fraction also found in the nucleus (1). Important
for embryo development and growth control, the H19-Igf2
locus has been implicated in two human genetic disor-
ders: Beckwith–Wiedemann Syndrome (BWS) and Silver–
Russell Syndrome (SRS). BWS is also associated with a
predisposition to tumorigenesis (1). Evidence supports a
growth-suppressing role ofH19 (2), although an oncogenic
role cannot be ruled out (3–6). Nuclear H19 binds EZH2
(a key component of Polycomb repressive complex 2) and
inhibits transcription of a selective group of genes, thereby
promoting bladder cancer metastasis (4). Likewise, through
interaction with MBD1 (methyl-CpG-binding protein 1)
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nuclear H19 inhibits expression of imprinted network genes
by recruiting repressive histone markers to their differen-
tially methylated regions, contributing to embryo growth
regulation (7). In addition to epigenetic modification, the
nuclear role of H19 extends to its ability to encode miR-
675, a microRNA (miRNA) embedded in its first exon and
whose release from H19 is developmentally tightly con-
trolled in the mouse (8,9). miR-675 functions to both reg-
ulate placental growth and maintain adult hematopoietic
stem cells, in part by post-transcriptionally inhibiting Igfr1
expression (9,10). Further, it acts to promote skeletal mus-
cle differentiation and regeneration (11).
Consistent with its predominantly cytoplasmic localiza-
tion, H19 has recently been shown to act as a molecular
‘sponge’ to sequester and regulate the let-7 family miRNAs
(12). While noncoding RNAs as miRNA sponges regulat-
ingmiRNA functions have been increasingly described (12–
20), whether these molecules are recriprocally regulated by
their target miRNAs, and how such regulation may occur,
remain unclear.
It has been reported that transgenic mice with inducible
muscle-specific overexpression of let-7 display insulin resis-
tance and impaired glucose tolerance, a phenotype that oc-
curs in part through let-7-mediated repression of multiple
components of the insulin-PI3K-mTOR pathway, includ-
ing insulin receptor (Insr), insulin receptor substrate 2 (Irs2)
and insulin-like growth factor receptor 1 (Igfr1) (21). Like-
wise, global let-7 overexpression in transgenic mice leads
to impaired glucose tolerance, whereas anti-miR-induced
let-7 downregulation both prevents and treats high fat diet
(HFD)-induced glucose intolerance, due at least in part to
improved insulin signaling as a result of derepression of let-
7 targets Insr and Irs2 in the muscle and liver (22). Thus,
genetic manipulation of let-7 level can cause altered glu-
cose metabolism (21,22). However, therein lies a paradox:
neither HFDmice (22) nor mice with muscle-specific Lin28
knockout (21) exhibited increased levels of let-7 in their
skeletal muscle, despite the fact that these mice were dia-
betic (21,22). Since Lin28 is a developmentally regulated
RNA-binding protein that functions to block processing of
primary let-7 transcripts (pri-let-7) to mature let-7 (23–25),
onewould predict thatmuscle-specific Lin28 knockoutmice
would have increased levels of let-7, but in fact this is not
the case (21). This raises the intriguing possibility that some
other factor, rather than Lin28, might regulate let-7 in mus-
cle.
In this report we demonstrate that H19 acts as an up-
stream regulator of let-7 in skeletal muscle cells; it reduces
the bioavailability of let-7 without altering its expression
level. Also, we reveal that there exists a double-negative reg-
ulatory feedback loop between let-7 and H19 that may un-
derlie glucose regulation in muscle cells.
MATERIALS AND METHODS
Antibodies, siRNAs, miRNAs and inhibitors
Antibodies for INSR (rabbit polyclonal, Bethyl Labora-
tories, Inc., A303–712A), Lipoprotein lipase (LPL) (mouse
monoclonal, Abcam, ab21356), -tubulin (rabbit poly-
clonal, Abcam, ab6046), Protein kinase B (AKT) (rabbit
polyclonal, Cell Signalling Technology, 9272), phospho-
AKT (Ser473) (rabbit polyclonal, Cell Signalling Tech-
nology, 9271), S6 ribosomal protein (rabbit monoclonal,
Cell Signalling Technology, 2217), phospho-S6 riboso-
mal protein (Ser235/236) (rabbit monoclonal, Cell Sig-
nalling Technology, 4856) and KH domain-containing
AU-rich element(ARE) binding protein (KSRP) (rabbit
polyclonal, Cell Signalling Technology, 2217) were pur-
chased. Inhibitors specific for AKT (124005 Akt inhibitor,
Calbiochem, 124005) and PI3K (LY294002, Selleckchem,
S1105) were purchased. TheAKT and PI3K inhibitors were
prepared inDimethyl sulfoxide (DMSO)with stock concen-
trations of 10 and 30 mM, respectively, and diluted in cul-
ture medium at 1:1000 to obtain working concentrations of
10 and 30 M, respectively.
Mouse H19-specific siRNA (simH19, 4390815/n25
3566), let-7a miRNA (AM17100/PM10050), miR16–1
miRNA (AM17100/PM10339), miR negative control
(miCon, AM17110), let-7 inhibitor (iLet-7, 4392431)
and anti-miR control (iCon, AM17010) were previously
described (12). The miR-16 inhibitor (imiR-16, 4464084)
and siKSRP targeting the mouse KSRP coding region
(5′-CAGGACAGUUUCACGACAACG-3′ (26–28)) were
purchased from Ambion.
Plasmids
psiCHECK2-let-7 4x was previously described (12).
To make psiCHECK2-LPL, polymerase chain re-
action (PCR) was carried out using adult mouse
muscle cDNA as a template and forward 5′-
ccgctcgagAGCTTGTAATTGAGGTGACAand reverse 5′-
aaggaaaaaagcggccgcCAGGAAGCTAAGGCAGGATG
primers. The resulting 190-bp mouse LPL (acces-
sion number BC003305) fragment was cloned to
psiCHECK2-let-7 4x opened with XhoI and NotI.
To make psiCHECK2-LPLmt, PCR was carried out
using psiCHECK2-LPL as a template and forward 5′-
ccgctcgagAGCTTGTAATTGAGGTGACA and reverse
5′-aaggaaaaaagcggccgcCAGGAAGCGAACTCACGATG
primers. The resulting 190-bp mouse LPL fragment with
point mutations was cloned to psiCHECK2-let-7 4x
opened with XhoI and NotI. The clones were verified by
sequencing.
Mouse muscle samples
Male C57BL/6 mice were maintained at 24◦C on a 12-
h:12-h light-dark cycle. Mice were fed a regular chow (Har-
lan Teklad 2018S) or HFD (60% kcal fat; Research Diets,
D12492) for seven weeks. Animals were fasted overnight
for 14 h before sampling. Mice were euthanized by cervi-
cal dislocation after anesthesia with isoflurane, and quadri-
ceps muscle was rapidly isolated and snap-frozen with pre-
cooled aluminum forceps and liquid nitrogen prior to stor-
age at −80◦C. All experiments were performed in accor-
dance with Yale’s Institutional Animal Care and Use Com-
mittee regulations.
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Human muscle samples
The study was approved by the local ethics committee in
accordance with the most recent version of the Helsinki
Declaration. Written consent was obtained from each sub-
ject after the purpose, nature and potential complications
of the studies had been explained. During muscle biopsy,
the skin over the lateral quadriceps muscle was sterilely pre-
pared with betadine, and 1% lidocaine was injected subcu-
taneously. A 2-cm incision was made using a scalpel and
a baseline punch muscle biopsy was extracted using a 5-
mm Bergstrom biopsy needle. A piece of muscle tissue was
dissected with scalpel and immediately blotted, snap frozen
and stored in liquid nitrogen until use. The characteristics
of the subjects (four healthy lean and five type-2 diabetes
(T2D)) are shown in the Supplementary Table S1.
Hyperinsulinemia/euglycemic clamp experiments
Twelve- to fourteen-week old male C57BL6/J mice main-
tained on regular chow (Harlan Teklad 2018S) underwent
surgery to implant indwelling catheters in the left jugular
vein. One week after surgery, mice were fasted overnight
and either euthanized with intravenous pentobarbital for
basal tissue or infused with 3 mU/kg/min insulin and 20%
dextrose to maintain euglycemia (∼120 mg/dl) for 140 min.
Plasma insulin levels were 45.8 −/+ 3.2 uU/ml at the end
of the experiment. Mice were euthanized, and gastrocne-
mius and quadriceps muscle were rapidly isolated and snap-
frozen with pre-cooled aluminum forceps and liquid nitro-
gen prior to storage at −80◦C. All experiments were per-
formed in accordance with Yale’s Institutional Animal Care
and Use Committee regulations.
Mouse C3H muscle myoblast culture and differentiation
Low passage C3H myoblast line was derived from normal
adult C3H mouse leg muscle (Sigma-Aldrich, 91031101-
1VL). Undifferentiated C3H myoblasts were maintained
in growth medium (GM) (Dulbecco’s modifiedEagle’s
medium (DMEM), Gibco, catalog number 11965-092, sup-
plemented with 10% Fetal Bovine Serum (FBS), heat in-
activated, 1% penicillin/streptomycin, 1% L-glutamine and
1-mM sodium pyruvate). To prepare for differentiation,
cells were typically seeded in 6-well plates at a density of
2.0 × 105 cells/well in GM. Differentiation was initiated 2
days later by replacingmediumwith differentiationmedium
(DM) (DM containing 2% horse serum in place of 10%
FBS). The medium was partially changed every other day
until use.
C3H myotube transfection
Transfection was performed at day 3 or 4 after initiation
of differentiation. Mytotubes were washed once with pre-
warmed OPTI-Minimal Essential Medium (OPTI-MEM)
immediately before addition of transfection cocktails. To
prepare transfection cocktails for each well of 6-well plates,
500-pmol of siCon or siH19 (with a stock solution of 5M)
was mixed with 600 l of OPTI-MEM by gentle pipetting.
In parallel 25l of Lipofectamine 2000was diluted in 600l
of OPTI-MEM by gentle pipetting. After 5 min incubation
at room temperature (RT), the twowere combined by gentle
pipetting. Following incubation at RT for 20min, the result-
ing cocktail (1200 l) was applied to myotubes that were
pre-washed with OPTI-MEM. After overnight incubation
in a tissue culture incubator, the cocktail was replaced with
fresh DM. Forty-eight hours later, RNA and protein were
extracted for analysis.
For miRNA transfection, 32 pmol of miCon or let-7a,
or 16 pmol of iCon or iLet-7 (with a stock concentration
of 5 M) was mixed with 400 l of OPTI-MEM by gentle
pipetting. In parallel, 4l of Lipofectamine 2000 wasmixed
with 400 l of OPTI-MEM. Following 5 min of RT incu-
bation, the two solutions were mixed and incubated at RT
for 20 min. The resulting 800l of transfection cocktail was
directly applied to one well of mytotubes pre-washed with
OPTI-MEM. After overnight incubation, the cocktail was
replaced with fresh DM. RNA and protein were extracted
48 h post-transfection for analysis.
Glucose uptake assay
These were performed in a 96-well plate scale. Glucose
uptake assays were carried out using the Glucose Uptake
Cell-Based Assay Kit (Cayman Chemical, catalog number
600470) according to the manufacturer’s instructions with
minor modifications. Briefly, 48 h after siRNA transfec-
tion, myotubes were incubated in 200 l of glucose-free
DMEM(Gibco, catalog number 11966–025) in the presence
or absence of 100 nM of insulin for 2 h. The medium was
then removed and replaced with 100 l of new glucose-free
DMEM containing fluorescent 2-NBDG at a final concen-
tration of 150 g/ml. Incubation was carried out in dark
for an additional 10 min in the tissue culture incubator.
The medium was then removed and the cells washed once
with 200 l of ice-cold phosphate buffered saline (PBS).
After adding 100 l of new ice-cold PBS to the cells, fluo-
rescent intensity was immediately determined using the flu-
orescent plate reader (FilterMax F3&F5 Multi-Mode Mi-
croplate Reader, Molecular Devices).
RNA stability analysis
To assess insulin effects on H19 RNA stability, C3H my-
otubes in 48-well plates were incubated with 100 nM of
insulin (HUMULIN R, Lilly USA, LLC, Indianapolis) in
DM in the presence of actinomycin D at a final concentra-
tion of 10 ug/ml for a total duration of 1.5 h. Total RNA
was harvested at 0, 30, 60 and 90 min and analyzed by RT-
qPCR. Results are presented after normalization against
beta-tubulin mRNA levels with 0 time point RNA levels ar-
bitrarily set as 1.
To evaluate let-7 effects on H19 RNA stability, miRNA
transfection (48-well plate scale) combined with actino-
mycin D time course analysis was performed. To prepare
transfection cocktail, 1 pmol of miCon or let-7a was mixed
with 50 l of OPTI-MEM. In parallel, 0.5 l of Lipofec-
tamine 2000 was mixed with 50 l of OPTI-MEM. Follow-
ing 5 min of incubation, the two solutions were mixed and
incubated at RT for 20 min. The resulting 100 l of trans-
fection cocktail was added to myotubes pre-washed with
OPTI-MEM. Upon adding the transfection cocktail, acti-
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nomycin D was also added to each well at a final concentra-
tion of 10 g/ml. Total RNA was extracted at 0, 1, 2 and
3 h, followed by RT-qPCR analysis. Results are presented
after normalization against beta-tubulin mRNA levels with
0 time point RNA levels arbitrarily set as 1.
PI3K/AKT inhibitor rescue experiments
These were performed in a 48-well plate scale. Day 3 my-
otubes were incubated with fresh 200 l of DM containing
30 M of PI3K inhibitor (group #1), 10 M of AKT in-
hibitor (group #2) or no inhibitors (groups #3 and #4). Af-
ter 30 min incubation, 200l of newDM containing 30M
of PI3K inhibitor plus 200 nM of Insulin (INS) was added
to group #1; 200 l of new DM containing 10 M of AKT
inhibitor plus 200 nMof INSwas added to group#2; 200l
of new DM containing 200 nM of INS was added to group
#3; and 200 l of new DM containing no inhibitors or INS
was added to group #4. Thus, the #1 and #2 groups were
exposed to both INS (at a final concentration of 100 nM)
and the respective inhibitors. The #3 group was exposed to
INS only, while the #4 group was exposed to none.Medium
was not removed at the end of 30 min pre-incubation to
avoid cell detachment. After 2 h, medium was removed and
cells in these four wells were lysed with Lysis Butter. Fol-
lowing regular RNA extraction, reverse transcription and
RT-qPCR was performed as described below.
RT-qPCR analysis
These were carried out essentially as previously described
(12). Briefly, total RNAs were extracted from cells us-
ing PureLink RNA Mini Kit (Ambion, catalog number
12183018A). cDNA was synthesized using Bio-Rad iS-
CRIPT kit (1725122) in a 20-l reaction containing 100–
500 ng of total RNA. Real-time quantitative PCR was per-
formed in a 15-l reaction containing 0.5–1 l of cDNA
using iQSYBRGreen (Bio-Rad) in a Bio-Rad iCycler. PCR
was performed by initial denaturation at 95◦C for 5 min,
followed by 40 cycles of 30 s at 95◦C, 30 s at 60◦C and 30
s at 72◦C. Specificity was verified by melting curve analy-
sis and agarose gel electrophoresis. The threshold cycle (Ct)
values of each sample were used in the post-PCR data anal-
ysis. The PCR primers for the indicated human, mouse and
rat genes are listed below.
HumanH19 forward: 5′- ACTCAGGAATCGGCTCTGG
AA
Human H19 reverse: 5′- CTGCTGTTCCGATGGTGTC
TT
Mouse H19 forward: 5′-CCTCAAGATGAAAGAAATG
GTGCTA
Mouse H19 reverse: 5′-TCAGAACGAGACGGACTTA
AAGAA
Rat H19 forward: 5′-ACTCCATCTTCATGGCCAAC
Rat H19 reverse: 5′-CAGAGTCACGGATGCTTTGA
Mouse Lpl forward: 5′-GGATCCGTGGCCGCAGCAG
ACGCAGGAAGA
Mouse Lpl reverse: 5′-GAATTCCATCCAGTTGATGAA
TCTGGCCAC
Mouse Igf2 forward: 5′-GCTTGTTGACACGCTTCAG
TTTG
Mouse Igf2 reverse: 5′-GTTGGCACGGCTTGAAGGC
Mouse INSR forward: 5′-GCTGGAGGAGTCTTCAT
TCA
Mouse INSR reverse: 5′-TGCCTGAAGAGGTTTTTCT
G
Human/mouse beta-tubulin forward: 5′-CGTGTTCGG
CCAGAGTGGTGC
Human/mouse beta-tubulin reverse: 5′-GGGTGAGGG
CATGACGCTGAA
Rat/mouse RPLP0 (36B4) forward: 5′-AGATGCAGCAG
ATCCGCAT
Rat/mouse RPLP0 (36B4) reverse: 5′-GTTCTTGCCCA
TCAGCACC
For miRNA quantification, total RNAs were extracted
from cells using PureLink RNA Mini Kit (Ambion, cata-
log number 12183018A). Levels of mature miRNAs were
determined by RT-qPCR using miScript reverse transcrip-
tion kit (catalog number 218161) andmiScript SYBRGreen
PCR kit (catalog number 218073) according to the manu-
facturers’ instructions. PCR primer sets (miScript primer)
specific for let-7a (MS00031220), miR16–1 (MS00006517),
miR-1 (MS00008358), miR-133 (MS00032305), miR-675
(MS00006398) and snRNA U6 (MS00033740) were pur-
chased fromQiagen. The indicated miRNA levels were nor-
malized against U6.
Western blot analysis
These were carried out essentially as previously described
(12). Briefly, cell or frozen tissue pellets were quickly lysed in
five volumes of 2x sodium dodecyl sulphate (SDS)-sample
buffer heated at 100◦C for 5 min, with occasional vortexing.
Five to tenmicroliters of homogenized samples were loaded
onto 10% SDS gel, followed by western blot analysis.
Luciferase assays
The assays were carried out in a 48-well plate scale as pre-
viously described (12). Briefly, 10 ng of the indicated lu-
ciferase reporter plus 140 ng of empty vector was trans-
fected into HEK293 cells (2 × 105 cell/well), together with
control miRNA or let-7 miRNAs at a final concentra-
tion of 24, 48 or 96 nM. Each concentration was run in
triplicates. Luciferase activities were measured 18 h post-
transfection using Promega Dual-Luciferase Reporter As-
say System (E1960) according to the manufacturer’s pro-
tocol. Renilla luciferase activities were normalized against
Firefly luciferase activities and presented as percentage of
inhibition.
Bioinformatic analysis
The sequences of human andmouse lipoprotein lipase (Lpl)
genes were retrieved from Genebank (http://www.ncbi.nlm.
nih.gov/gene) using their corresponding accession numbers
of BC011353.1 and BC003305, respectively. The sequences
of human and mouse mature miRNAs were retrieved from
miRBase (http://www.mirbase.org/). The binding sites of
let-7 miRNA on Lpl mRNAs were predicted using a web-
based program RNAhybrid (12).
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Figure 1. H19 is downregulated in skeletal muscle of diabetic human subjects and high fat diet (HFD) induced insulin resistant and diabetic mice. (A)
Relative H19 expression in non-diabetic (Ctr) versus T2D human/HFD mouse muscle. Numbers of mice and human subjects are indicated in the paren-
thesis. (B) Relative Insr and Lpl mRNA levels in Ctr versus HFDmouse muscle. (C) Protein lysates from muscle of Ctr or HFDmice were used to analyze
expression levels of Insr and Lpl by western blot analysis. Beta-tubulin (TUBB) was used as a loading control. Quantifications of the western blot bands
are shown on the right. (D) Relative let-7 levels in Ctr versus HFD mouse muscle. All data are presented as mean ± SEM. *P < 0.05; **P < 0.01.
Statistical analysis
All data are presented as mean ± SEM. Data were ana-
lyzed using two-tailed Student’s t-test. P-values of 0.05 or
less were considered significant.
RESULTS
Decreased H19 expression correlates with impaired glucose
homeostasis in human and mouse
Both human and mouse skeletal muscle express high lev-
els of H19 (1,29). Intriguingly, we observed that the H19
level was ∼5-fold downregulated in muscle of both human
subjects with T2D and insulin resistant mice, as compared
to healthy controls (Figure 1A). HFD-induced obesity is a
well-characterized mouse model of obesity-induced insulin
resistance and T2D (22). We previously identified three let-
7-binding sites in mouse H19 (Supplementary Figure S1,
(12)). Given that H19 sequesters let-7, preventing it from
inhibiting target gene expression (12), we hypothesized that
decreased levels of H19 would lead to less sequestration
of let-7, causing more let-7 to be available to inhibit tar-
get gene expression, hence contributing to and exacerbat-
ing insulin resistance and T2D. To test the hypothesis, we
examined expression of two let-7 targets, Insr and Lpl. The
Insr (composed of two extracellular -subunits linked to a
transmembrane-spanning -subunit) is responsible for in-
sulin action in peripheral tissues including liver, fat and
skeletal muscle and is a key player in the evolutionarily con-
served insulin-PI3K-mTOR signaling pathway that regu-
lates growth and glucose metabolism (21,22,30). The Insr
genes of both human and mouse contain a single let-7-
binding site in their 3′-UTRs (21,22). The lipoprotein li-
pase is most widely distributed in adipose, heart and skele-
tal muscle tissue. It hydrolyzes triglycerides in lipoproteins
into fatty acids and monoacylglycerol molecules for tissue
utilization and also promotes cellular uptake of free fatty
acids, cholesterol-rich lipoproteins and chrylomicron rem-
nants (31). In addition to its central role in lipidmetabolism,
lipoprotein lipase has a function of regulating mitochon-
drial biogenesis. Indeed, decreased lipoprotein lipase level
contributes to reduced mitochondrial number, and down-
regulation of Lpl and mitochondrial number in muscle of
young lean insulin resistant offspring of parents with T2D
have been documented (32). Based on a strong relationship
between diminished mitochondrial number and muscle in-
sulin resistance (33–35), a role of lipoprotein lipase in glu-
cose metabolism has been proposed (32).
We identified let-7-binding sites in the 3′-UTR of Lpl
mRNAof both human (position 2143) andmouse (position
2940) (Supplementary Figure S2). Importantly, the expres-
sions of Insr and Lpl were significantly decreased at both
RNA (Figure 1B) and protein (Figure 1C) levels in HFD
muscle compared to normal controls. Consistent with pre-
vious reports (22), there was no significant difference in the
let-7 level between the two groups (Figure 1D). These re-
sults suggested that downregulation of H19 increased the
bioavailability of let-7 without affecting its level, leading to
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Figure 2. The H19/let-7 axis regulates expression of insulin receptor and
lipoprotein lipase. C3Hmyotubes were transfected with the indicated mix-
ture. Protein and RNA were extracted 48 h later and levels determined by
RT-qPCR (A and C) and western blot (B) analyses. In (B), quantification
of western gels from three independent experiments are shown on the right.
All data are presented as mean ± SEM. (n = 3); *P < 0.05; **P < 0.01.
decreased expression of Insr and Lpl. Further, while H19
was diminished in the HFDmuscle (Supplementary Figure
S3A), the levels of miR-675 and Igf2 were not significantly
altered (Figure S3B and C), suggesting that miR-675 and
Igf2 were likely not associated with the HFD effects.
To provide further evidence that the decreased expres-
sion of Insr and Lpl was indeed mediated by let-7, we per-
formed siRNA knockdown combined with let-7 inhibition
experiments in myotubes differentiated from mouse C3H
myoblasts. The specific questions we asked were whether
H19 knockdown would reduce the expression of Insr and
Lpl and whether co-transfection of a let-7-specific inhibitor
(iLet7) concomitant with H19 knockdown would reverse
this effect. iLet7 is a chemically-modified, single-stranded
nucleic acid that specifically binds to and inhibits endoge-
nous let-7 molecules (12). Thus, C3H myotubes were trans-
fected with a mix of siCon (control siRNA) and iCon (con-
trol miRNA inhibitor), a mix of simH19 (a siRNA specific
for mouse H19, (12)) and iCon or a mix of simH19 and
iLet7. Protein and RNA were extracted and analyzed 48 h
post-transfection. Results from control experiments using
siCon, simH19, iCon or iLet7 alone are also shown (Sup-
plementary Figure S4). When H19 was knocked down by
∼80% (Figure 2A, left column, compare red bar to blue
bar), the mRNA levels of both Insr and Lpl were reduced
significantly (middle and right columns, compare red bars
to blue bars). In contrast, when H19 was knocked down
(left column, compare green bar to blue bar) but at the same
time iLet7 was also present, a decrease in the Insr and Lpl
mRNA levels was not observed (middle and right columns,
compare green bars to blue bars). The changes in Insr and
Lpl expression at the protein level in response toH19 knock-
down and iLet7 rescue were consistent with those ofmRNA
levels (Figure 2B). Together, these results suggested that the
effects of H19 knockdown on Insr and Lpl expression were
indeedmediated by let-7.WhileH19 depletion did not affect
let-7 levels (Figure 2C, compare red bars to blue bars across
the columns), co-transfection with iLet7 led to modest de-
creases in let-7 levels (compare green bars to blue bars),
consistent with targeted let-7 degradation by antisense in-
hibitors (22). Collectively, our results further underscore the
notion that H19 facilitates expression of Insr and Lpl in
muscle cells by reducing the bioavailability of let-7.
H19 depletion impairs insulin sensitivity of muscle cells
Ahallmark of heightened glucose metabolism is an increase
in glucose uptake, which can be assessed quantitatively us-
ing well-established methods involving radioactive or non-
radioactive glucose tracers. To assess the biological signifi-
cance of H19 in glucose metabolism, we analyzed effects of
H19 downregulation on insulin-stimulated glucose uptake
in C3H myotubes. We used a non-radioactive glucose up-
take method that employs 2-NBDG, a fluorescently-labeled
deoxyglucose analog, as a tracer for direct monitoring of
glucose transport in live cells. Thus, siCon or simH19 was
transfected into myotubes, followed by glucose uptake as-
says 48 h post transfection. As expected, in response to H19
depletion the let-7 targets were downregulated at bothRNA
(Figure 3A, second and third columns, compare red bars to
blue bars) and protein (Figure 3B, compare lanes 2 to lanes
1 on the left, and red bars to blue bars on the right) levels.
Importantly, in myotubes transfected with siCon, insulin
stimulated glucose uptake by ∼2-fold (Figure 3C, left col-
umn, compare red bar to green bar). In contrast, there was
no insulin-dependent stimulation of glucose uptake in my-
totubes transfected with simH19 (Figure 3C, right column,
compare red bar to green bar). Consistent with an impaired
insulin-PI3K-mTOR signaling, there was decrease in phos-
phorylation of both Akt and S6 in simH19-transfected ver-
sus siCon-transfectedmyotubes (Figure 3D, compare lane 3
to 1 in top andmiddle blots, respectively). Combining our in
vivo (Figure 1) with in vitro (Figures 2 and 3) results, we sug-
gest that decreased H19 in diabetic muscle cells may cause
increased bioavailability of let-7, which in turn suppresses
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Figure 3. H19 regulates glucose uptake by affecting the insulin-PI3K-mTOR pathway. C3H myotubes were transfected with siCon or simH19. RNA and
proteins were extracted and analyzed by RT-qPCR (A) and western blot (B) 48 h post transfection. Numbers are mean ± SEM (n = 3). *P < 0.05; **P
< 0.01. (C) C3H myotubes were transfected with siCon or simH19. Glucose uptake was measured 48 h post-transfection. Results are presented as relative
glucose uptake with values in absence of insulin stimulation set as 1. Numbers are mean ± SEM (n = 6). **P < 0.01. (D) Western blot analysis of effects
of H19 knockdown on insulin-PI3K-mTOR signaling. C3H myotubes transfected with siCon or simH19 were insulin stimulated (+) or not stimulated (−)
for 30 min. Proteins were extracted and analyzed using antibodies specific for the phosphorylated [p-Akt(S473)/p-S6] or total [Akt/S6] proteins known to
be involved in the pathway. Beta-tubulin was used as loading controls.
expression of Insr and Lpl. We propose that H19 may con-
tribute to muscle glucose regulation by acting as a novel up-
stream regulator of let-7.
Acute hyperinsulinemia downregulates H19 in non-diabetic
muscle
A hallmark of T2D is decreased insulin-stimulated glucose
uptake accompanied by compensatory hyperinsulinemia (a
condition in which there are excess levels of insulin circulat-
ing in the blood) (36,37).While the cause of diminishedH19
expression in T2D muscle is unknown, we observed H19
downregulation in muscle of non-diabetic rodents follow-
ing acute hyperinsulinemia in hyperinsulinemic-euglycemic
clamp studies. We used well-established conditions by the
NIH-fundedMouseMetabolic PhenotypingConsortium in
which both skeletal muscle insulin signaling and glucose
transport are stimulated during the experiments (38).
Thus, following a 14 h overnight fast, healthy non-
diabetic mice received a fixed infusion of insulin (3
mU/kg/min) and a variable infusion of 20% dextrose to
maintain euglycemia for 140 min. In parallel, overnight
fasted mice that had also undergone surgery were sacri-
ficed for non-insulin stimulated tissue. Gastrocnemius and
quadriceps muscle were isolated, followed by RNA extrac-
tion and RT-qPCR analysis. We observed an ∼80% de-
crease in H19 level at 140 min of hyperinsulinemia com-
pared to the control (Figure 4A). Similar results were
obtained from hyperinsulinemic-euglycemic clamp stud-
ies performed on non-diabetic rats (Supplementary Figure
S5A). Our bioinformatic analyses predicted binding sites
for six let-7 subtypes in rat H19 (12). In addition, HFD rats
showed decreased levels of H19 in the skeletal muscle (Sup-
plementary Figure S5B), as is the case for HFD mice (Fig-
ure 1A, right panel). Importantly, the hyperinsulinemia-
inducedH19 downregulation was recapitulated in C3Hmy-
otubes in which a high dose (100 nM) of insulin stimulation
for 2 h led to H19 decrease by ∼60% (Figure 4B).
Regulation of H19 expression has been shown to occur
mainly at the transcriptional level during mouse fetal devel-
opment but at the post-transcriptional level during muscle
cell differentiation (39). We thus asked whether the rapid
H19 downregulation observed (Figure 4A and B) could be a
result of H19 destabilization. H19 had a significantly faster
decay rate in insulin stimulated versus un-stimulated my-
otubes (Figure 4C, left panel, compare red-dotted line with
blue-dotted line), whereas no decay rate differences were
observed with gapdh mRNA (right panel), suggesting that
insulin-stimulated H19 downregulation occurs at least in
part through RNA destabilization.
Downregulation of H19 is mediated by let-7
We noted previously that let-7 overexpression causes H19
level decline in let-7-transfected myotubes (12). We also
noted that let-7 interacts with H19 in Ago2-containing
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Figure 4. High dose insulin downregulates H19 both in vivo and in vitro.
(A) H19 levels from skeletal muscle of non-diabetic mice subjected to
clamp studies. INS+, with insulin infusion; INS−, without insulin infu-
sion. Numbers are mean ± SEM. **P < 0.01. (B) C3H myotubes were
stimulated (INS+) or un-stimulated (INS−) with 100 nM of insulin for 2
h. RNAs were extracted and analyzed by RT-qPCR. Numbers are mean
± SEM. (n = 3); **P < 0.01. (C) C3H myotubes were stimulated or un-
stimulated by 100 nM of insulin in the presence of transcription inhibitor
actinomycin D at a final concentration of 10 g/ml. RNAs were collected
at the indicated time points and levels determined by RT-qPCR. Results
are presented after normalization against beta-tubulin mRNA, with zero
time point mRNA levels arbitrarily set as 1. Numbers are mean ± SEM.
(n = 3); **P < 0.01.
RNPs (12). To test the possibility that binding of let-7 to
H19 might induce H19 degradation, we transfected let-7 or
miCon (control miRNA) into C3H myotubes, followed by
RNA stability analysis. The decay rate ofH19was increased
in cells transfected with let-7 compared to control miRNA
(Supplementary Figure S6), consistent with let-7-mediated
H19 destabilization. These observations prompted us to ask
whether acute high dose insulin stimulation might increase
let-7 levels, thereby promoting H19 destabilization. Thus,
C3H myotubes were stimulated with 100 nM of insulin for
2 h and expression of let-7 was analyzed. The level of let-7
increased by∼3-fold in response to insulin stimulation (Fig-
ure 5A), consistent with the notion that increased let-7 has a
causative effect on H19 destabilization. Further, transfect-
ing let-7 into myotubes resulted in decreased H19 expres-
sion (Figure 5B, compare middle column with left column),
while transfecting miR-16 (predicted not to bind H19 (12))
did not (Figure 5B, left column). Thus, under our experi-
mental conditions H19 destabilization appeared to be let-7-
specific, although other mechanisms of action could not be
ruled out.
To provide further evidence to support a let-7-specific ef-
fect, myotubes were transfected with iCon, iLet7 or imiR-
16 (miR-16-specific inhibitor). Following overnight incuba-
tion, transfected cells were treated with or without 100 nM
of insulin for 2 h.RNAswere extracted and analyzed byRT-
qPCR. Both iCon- and imiR-16-transfected cells showed
a decrease in the H19 level in response to insulin (Fig-
ure 5C, first two columns from left, compare red bars to
blue bars). However, the decrease in H19 level no longer oc-
curred with insulin in iLet7-transfected cells (right column,
compare red bar with blue bar). Taken together these re-
sults led us to speculate that in C3H myotubes, high dose
insulin upregulates let-7, which in turn downregulates H19.
As hyperinsulinemia downregulates H19 in rodent skele-
tal muscle (Figure 4A and Supplemental Figure S5A), we
predicted that hyperinsulinemia would upregulate let-7 in
muscle, which indeed was the case. As demonstrated from
our hyperinsulinemic-euglycemic clamp studies performed
on non-diabetic mice, a high dose insulin perfusion for 140
min led to a∼2.5-fold increase in themature let-7 level (Fig-
ure 5D), suggesting that increased let-7 production likely
contributes to H19 downregulation in vivo.
Let-7 upregulation requires KSRP and involves
insulin/PI3K/AKT signaling
What could be the underlying mechanism of let-7 upreg-
ulation? It was recently reported that treating C3H my-
otubes with a high dose of insulin (100 nM) caused in-
creased production of mature myogenic miRNAs, miR-1
and miR-133, as a result of enhanced processing of their
primary transcripts (pri-miRNAs) (26). This enhanced pro-
cessing required the RNA-binding protein KSRP, which
was phosphorylated upon PI3K/AKT activation by insulin
(26). Phosphorylation of KSRP by AKT enhanced KSRP’s
ability to interact with the myogenic pri-miRNAs and their
processing into mature forms (26). This KSRP-dependent,
insulin/PI3K/AKT-induced upregulation of miR-1 and
miR-133 was recapitulated under our experimental condi-
tions. Thus, we inhibited PI3K/AKT signaling in C3H my-
otubes using inhibitors shown to specifically inhibit the re-
spective kinases at the indicated dosages (40–42), followed
by examination of effects on expression of miR-1 and miR-
133. The levels of mature miR-1 andmiR-133 increased fol-
lowing 2 h insulin stimulation (Figure 6A, compare the sec-
ond to the first bar from left), and were partially restored
to those of non-insulin stimulated in the presence of ei-
ther inhibitor (Figure 6A, compare third and fourth bars
to the first). Further, when KSRP was silenced using a well-
characterized siRNA specific for mouse KSRP (siKSRP)
(26–28) (Supplementary Figure S7), the insulin-induced up-
regulation of bothmiRNAswas abolished (Figure 6B, com-
pare right columns with the left). Together, our results are
consistent with previous reports demonstrating that high
dose insulin stimulation promotes biogenesis of miR-1 and
miR-133 via a KSRP- and PI3K/AKT-dependent mecha-
nism (26).
Given that KSRP also promotes processing of other
pri-miRNAs including that of let-7 (27,43,44), we asked
whether insulin-induced let-7 upregulation requires KSRP
and whether it involves PI3K/AKT signaling. As expected,
insulin induced an increase in mature let-7 by ∼2.5-fold in
siCon-transfected C3H myotubes (Figure 6C, upper panel,
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Figure 5. Insulin upregulates let-7 both in vitro and in vivo. (A) C3H myotubes were stimulated or un-stimulated with 100 nM of insulin for 2 h, followed
by RNA extraction and RT-qPCR analysis. Relative levels of let-7 are shown. (B) C3H myotubes were transfected with control miRNA (miCon), let-7, or
miR-16. RNAs were extracted 4 h later and RT-qPCR analysis performed. Relative H19 levels are presented with that of miCon-transfected arbitrarily set
as 1. (C) C3Hmyotubes were transfected with iCon, imiR-16, or iLet7. After overnight incubation, transfected cells were stimulated or un-stimulated with
100 nM of insulin for 2 h. RNAs were extracted and analyzed by RT-qPCR. (D) Let-7 levels from skeletal muscle of non-diabetic mice subjected to clamp
studies. All data are presented as mean ± SEM. (n = 3 when not indicated); **P < 0.01.
left column, compare red bar to blue bar). This insulin-
dependent increase was abrogated when KSRP was down-
regulated (right column), consistent with a requirement for
KSRP for insulin-induced upregulation of let-7. Also as ex-
pected, the level of H19 decreased when let-7 was upreg-
ulated in siCon- but not in siKSRP-transfected myotubes
(Figure 6C, bottom panel), further supporting the role of
let-7 in mediating H19 destabilization.
To address whether activation of PI3K/AKT signaling
plays a role in insulin-induced let-7 upregulation and H19
downregulation, C3H myotubes were treated with 100 nM
of insulin for 2 h in the presence or absence of kinase in-
hibitors, followed by RT-qPCR analysis. While insulin in-
creased let-7 levels (Figure 6D, compare the second to the
first bar from left), co-incubation with either inhibitor abol-
ished this insulin-dependent effect (compare the third and
fourth bars to the second and first bars). Importantly, re-
sponse of H19 to these inhibitors was consistent with let-7′s
role as a negative regulator of its stability (Figure 6D, bot-
tom panel). Taken together, these results strongly support a
model in which KSRP and its PI3K/AKT-dependent acti-
vation play a role in the insulin-induced let-7 upregulation,
which mediates H19 destabilization following acute hyper-
insulinemia in non-diabetic muscle.
Insulin signaling remains intact during acute hyperinsuline-
mia in non-diabetic muscle
Following 100 nM of insulin stimulation of myotubes for
2 h (acute phase), the level of H19 decreased, as did the
mRNA levels of Lpl and Insr (Figure 6E, top panel, com-
pare red bars to blue bars). The level of H19 returned to
normal at 24 h (later time point) following a single dose of
insulin, although those of Lpl and Insr remained low (Fig-
ure 6E, bottom panel). Western blot analysis confirmed de-
creased protein levels of Lpl and Insr at 24 h post insulin
stimulation (compare lane 2 to lane 1 in the top two blots
in Figure 6F; pink bars to blue bars in Figure 6G), but not
at 2 h (data not shown), which was not surprising as the 2
h time frame would not be sufficient to detect protein level
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Figure 6. Let-7 upregulation requires KSRP and PI3K/AKT signaling. (A) C3H myotubes were stimulated (INS+) or un-stimulated (INS−) with 100
nM of insulin for 2 h, in the presence or absence of indicated kinase inhibitors. miRNAs were extracted and subjected to RT-qPCR analysis. Relative
levels of mature miR-1 and miR-133 are shown on top and bottom panels, respectively. (B and C) C3H myotubes were transfected with siCon or siKSRP.
Forty-eight hours later, cells were stimulated or un-stimulated with 100 nM of insulin for 2 h, following by RNA extraction and RT-qPCR analysis. (D)
C3H myotubes were stimulated (INS+) or un-stimulated (INS−) with 100 nM of insulin for 2 h, in the presence or absence of indicated kinase inhibitors.
RNAs were extraction and subjected to RT-qPCR analysis. Relative levels of let-7 and H19 are shown on top and bottom panels, respectively. All data
are presented as mean ± SEM. (n = 3); **P < 0.01. (E) C3H myotubes were stimulated (INS+) or un-stimulated (INS−) with 100 nM of insulin. RNAs
were extraction at 2 h (top panel) or 24 h (bottom panel) and subjected to RT-qPCR analysis. Relative RNA levels are shown after normalization against
beta-tubulin. Numbers are mean ± SEM. (n = 3); **P < 0.01. (F) Proteins were extracted from C3H myotubes 24 h following stimulation with a single
dose of 100 nM insulin (INS+) or no INS stimulation (INS−) and analyzed by western blot using antibodies against LPL (top blot), INSR (middle blot)
and TUBB (bottom blot). (G) Quantification of western blot gels from three independent experiments. Numbers are presented as mean ± SEM. (n = 3);
**P < 0.01.
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Figure 7. A proposed protective mechanism mediated by the H19/let-7
axis. Under normal conditions in non-diabetic muscle there exists a home-
ostasis with high H19 and low let-7 availability. During acute hyperinsu-
linemia, the PI3K/AKT pathway is activated, causing let-7 level rise and
rapid H19 degradation. Such H19 depletion and release of let-7 leads to
temporal impairment of insulin signaling at later time points, thus pre-
venting muscle cells from overdrawing glucose from the circulation.
changes. Thus, insulin signaling would remain intact dur-
ing acute phase but impaired at later time points when Insr
and Lpl protein levels begin to fall. This would be consis-
tent with the fact that hyperinsuinemia stimulates glucose
uptake during acute phase in non-diabetic rodents (38) and
that high dose insulin (100 nM) stimulates glucose uptake in
siCon-transfected (but not simH19-transfected) C3H my-
otubes (Figure 3C).
DISCUSSION
Both our in vivo and in vitro studies suggest that H19 may
regulate muscle glucose metabolism by acting as a novel up-
stream regulator of let-7 whose role in glucose metabolism
has been firmly established (21,22). We provide evidence
that in diabetic muscle decreased H19 leads to increased
bioavailability of let-7, which in turn inhibits expression of
key metabolic genes such as Insr and Lpl. On the other
hand, let-7 targets H19 for degradation during acute hy-
perinsulinemia in non-diabetic muscle. Thus, there exists a
double-negative feedback loop between H19 and let-7 that
contributes to glucose regulation in muscle. Our results also
help to explain, at least in part, the paradox phenomenon
that HFDmice have impaired glucose metabolism but with
a normal level of let-7 in their skeletal muscle (22).
Our finding that let-7 targets H19 for destabilization in
response to extracellular cues establishes the first example
of miRNAs regulating their own sponges as a part of a reg-
ulatory feedback loop. This regulation appears to serve as
a protective mechanism in non-diabetic individuals. Results
from both in vivo (Figures 4D and 5A) and in vitro (Fig-
ures 4A and 5B) studies demonstrate that acute high dose
insulin stimulation increases let-7 and decreases H19, and
that these effects are dependent on intact insulin signaling,
as such effects are not observed in HFD muscle (Supple-
mentary Figure S8). This suggests that in healthy individu-
als the ‘off-signal’ for the H19/let-7 axis is the normal rise
and fall of plasma insulin following regular meals. During
acute hyperinsulinemia, the axis is activated and serves as a
protective mechanism to prevent muscle from overusing cir-
culatory glucose at later time points which otherwise would
be toxic to the muscle (Figure 7). The axis corrects itself
following acute high insulin assault, which is supported by
results from C3H myotubes (Figure 6E–G).
Unfortunately, the available H19 deletion mouse mod-
els are not suitable for studying H19-mediated regulation
of glucose metabolism due to complex regulatory circuitry
involving the imprinted gene network that controls embryo
growth andmuscle development (1,7,45,46). Further, global
and constitutive H19 knockout could induce developmen-
tally compensatory mechanisms that confound data inter-
pretations. Further studies using transgenic mouse models
that allow muscle-specific and inducible expression of H19
shRNA will be necessary to firmly establish the in vivo role
for H19 in glucose metabolism.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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